Efficacy of Afatinib, Erlotinib, and Gefitinib on epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) patients with brain metastasis: a network meta-analysis

Mapping Intimacies ◽

10.1183/13993003.congress-2018.pa2802 ◽

2018 ◽

Author(s):

So-My Koo ◽

Ki-Up Kim ◽

Yang-Ki Kim ◽

Soo-Taek Uh

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Download Full-text

76: Patterns of extra-cranial disease progression in epidermal growth factor receptor (EGFR) mutant metastatic non-small cell lung cancer (NSCLC) patients on a tyrosine kinase inhibitor (TKI)

Lung Cancer ◽

10.1016/s0169-5002(15)50075-5 ◽

2015 ◽

Vol 87 ◽

pp. S30 ◽

Author(s):

K. Aitken ◽

S. Popat ◽

C. Nutting ◽

F. McDonald

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Mutant ◽

Download Full-text

Atezolizumab and Bevacizumab in Epidermal Growth Factor Receptor (EGFR) Mutant Non‐Small Cell Lung Cancer in Patients With Progressive Disease After Receiving Osimertinib

Case Medical Research ◽

10.31525/ct1-nct04099836 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Progressive Disease ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

P37.17 Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.764 ◽

2021 ◽

Vol 16 (3) ◽

pp. S449

Author(s):

B. Melosky ◽

E. Laack ◽

K. Kambartel ◽

M. Häntschel ◽

M. Bennetts ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth

Download Full-text

135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01977-8 ◽

2021 ◽

Vol 16 (4) ◽

pp. S770-S771

Author(s):

J. Subramanian ◽

Y-L. Choi ◽

T-Y. Chou ◽

J. Gregg ◽

R. Hui ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Advanced Stage ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

Assessment of epidermal growth factor receptor (EGFR) and K-ras mutation status in cytologic stained smears of non-small cell lung cancer (NSCLC) patients.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7560 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7560-7560

Author(s):

M. D. Lozano ◽

A. Gurpide ◽

J. I. Echeveste ◽

A. Del Barrio ◽

J. L. Perez-Gracia ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Ras Mutation ◽

Mutation Status ◽

Epidermal Growth ◽

Download Full-text

The plasma level of soluble epidermal growth factor Receptor (EGFR) and overall survival (OS) in non-small-cell lung cancer (NSCLC) patients.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e19091 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e19091-e19091 ◽

Author(s):

Ping Ye ◽

Jing Zhao ◽

Shulian Wang ◽

Feng Ming Kong

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Plasma Level ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

9016 POSTER DISCUSSION Erlotinib Vs Chemotherapy (CT) in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Epidermal Growth Factor Receptor (EGFR) Activating Mutations – the EURTAC Phase II Randomized Trial Interim Results

European Journal of Cancer ◽

10.1016/s0959-8049(11)72328-0 ◽

2011 ◽

Vol 47 ◽

pp. S597 ◽

Author(s):

F. De Marinis ◽

R. Rosell ◽

A. Vergnenegre ◽

B. Massuti ◽

E. Felip ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Activating Mutations ◽

Epidermal Growth ◽

Download Full-text

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

Lung Cancer ◽

10.1016/j.lungcan.2014.02.011 ◽

2014 ◽

Vol 84 (2) ◽

pp. 161-167 ◽

Author(s):

Noemi Reguart ◽

Rafael Rosell ◽

Felipe Cardenal ◽

Andres F. Cardona ◽

Dolores Isla ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

The Plasma Concentration of Epidermal Growth Factor Receptor (EGFR) and Overall Survival (OS) in Non-Small Cell Lung Cancer (NSCLC) Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.1681 ◽

2015 ◽

Vol 93 (3) ◽

pp. E445

Author(s):

P. Ye ◽

J. Zhao ◽

N. Maihle ◽

S.L. Wang ◽

J.Y. Jin ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Epidermal Growth Factor Receptor ◽

Plasma Concentration ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text

9004 ORAL BRCA1 and Astrocyte Elevated Gene-1 (AEG-1) Expression and Outcome of Erlotinib-Treated Non-Small-Cell Lung Cancer (NSCLC) Patients (p) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations

European Journal of Cancer ◽

10.1016/s0959-8049(11)72316-4 ◽

2011 ◽

Vol 47 ◽

pp. S593

Author(s):

M. Taron ◽

S.B. Benlloch ◽

J.J.S. Sanchez ◽

R.R. Rosell ◽

C.C. Costa ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Download Full-text